These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 6185151)

  • 1. The effects of N-B transition of human serum albumin on the specific drug-binding sites.
    Wanwimolruk S; Birkett DJ
    Biochim Biophys Acta; 1982 Dec; 709(2):247-55. PubMed ID: 6185151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Consequences of the N-B transition of albumin for the binding of warfarin in human serum.
    van der Giesen WF; Wilting J
    Biochem Pharmacol; 1983 Jan; 32(2):281-5. PubMed ID: 6870956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel binding site for bile acids on human serum albumin.
    Takikawa H; Sugiyama Y; Hanano M; Kurita M; Yoshida H; Sugimoto T
    Biochim Biophys Acta; 1987 Nov; 926(2):145-53. PubMed ID: 2444264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural requirements for drug binding to site II on human serum albumin.
    Wanwimolruk S; Birkett DJ; Brooks PM
    Mol Pharmacol; 1983 Nov; 24(3):458-63. PubMed ID: 6195516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of pH, calcium and chloride ions on the binding of tolmetin to human serum albumin: circular dichroic, dialysis and fluorometric measurements.
    Matsuyama K; Sen AC; Perrin JH
    J Pharm Pharmacol; 1987 Mar; 39(3):190-5. PubMed ID: 2883283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for the fatty acid-induced heterogeneity of the N and B conformations of human serum albumin.
    Dröge JH; Janssen LH; Wilting J
    Biochem Pharmacol; 1985 Sep; 34(18):3299-304. PubMed ID: 4038338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of albumin conformation on the binding of warfarin to human serum albumin. The dependence of the binding of warfarin to human serum albumin on the hydrogen, calcium, and chloride ion concentrations as studied by circular dichroism, fluorescence, and equilibrium dialysis.
    Wilting J; van der Giesen WF; Janssen LH; Weideman MM; Otagiri M; Perrin JH
    J Biol Chem; 1980 Apr; 255(7):3032-7. PubMed ID: 7358725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cephalosporin binding sites to human serum albumin and the relation with the N-B transition of this protein.
    Nerli B; García F; Ballán C; Picó G
    Biochem Mol Biol Int; 1995 May; 36(1):177-84. PubMed ID: 7663413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of drug binding sites on mammalian albumins.
    Panjehshahin MR; Yates MS; Bowmer CJ
    Biochem Pharmacol; 1992 Sep; 44(5):873-9. PubMed ID: 1382424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoacylglycerol binding to human serum albumin: evidence that monooleoylglycerol binds at the dansylsarcosine site.
    Thumser AE; Buckland AG; Wilton DC
    J Lipid Res; 1998 May; 39(5):1033-8. PubMed ID: 9610770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactive binding to the two principal ligand binding sites of human serum albumin: effect of the neutral-to-base transition.
    Yamasaki K; Maruyama T; Yoshimoto K; Tsutsumi Y; Narazaki R; Fukuhara A; Kragh-Hansen U; Otagiri M
    Biochim Biophys Acta; 1999 Jul; 1432(2):313-23. PubMed ID: 10407153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of valproic acid, its unsaturated metabolites and some structurally related fatty acids on the binding of warfarin and dansylsarcosine to human albumin.
    Panjehshahin MR; Bowmer CJ; Yates MS
    Biochem Pharmacol; 1991 Apr; 41(8):1227-33. PubMed ID: 1706921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The fatty-acid-induced conformational states of human serum albumin investigated by means of multiple co-binding of protons and oleic acid.
    Dröge JH; Janssen LH; Wilting J
    Biochem J; 1988 Mar; 250(2):443-6. PubMed ID: 2833243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of nonenzymatic glycation and fatty acids on functional properties of human albumin.
    Lautenslager GT; Shearman CW; Hud E; Cohen MP
    Metabolism; 2011 Dec; 60(12):1683-91. PubMed ID: 21632076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug binding sites on chicken albumin: a comparison to human albumin.
    Rajaian H; Symonds HW; Bowmer CJ
    J Vet Pharmacol Ther; 1997 Dec; 20(6):421-6. PubMed ID: 9430764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conformational changes in human serum albumin around the neutral pH from circular dichroic measurements.
    Wilting J; Weideman MM; Roomer AC; Perrin JH
    Biochim Biophys Acta; 1979 Aug; 579(2):469-73. PubMed ID: 43743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding sites of fluorescent probes on human serum albumin.
    Muller N; Lapicque F; Drelon E; Netter P
    J Pharm Pharmacol; 1994 Apr; 46(4):300-4. PubMed ID: 7519671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative study of some physico-chemical properties of human serum albumin samples from different sources--II. The characteristics of the N-B transition and the binding behaviour with regard to warfarin and diazepam.
    Dröge JH; Wilting J; Janssen LH
    Biochem Pharmacol; 1982 Dec; 31(23):3781-6. PubMed ID: 7159460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of albumin conformation in the binding of diazepam to human serum albumin.
    Wilting J; Hart BJ; De Gier JJ
    Biochim Biophys Acta; 1980 Dec; 626(2):291-8. PubMed ID: 7213648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human serum albumin as an allosteric two-state protein. Evidence from effects of calcium and warfarin on proton binding behaviour.
    Janssen LH; Van Wilgenburg MT; Wilting J
    Biochim Biophys Acta; 1981 Jul; 669(2):244-50. PubMed ID: 7284438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.